will tirzepatide stop being compounded Compounded' weight-loss drugs are a growing problem for state regulators • Stateline What are the changes to

It targets several key pathways: The Hypothalamus: It acts on the brains appetite centers to increase feelings of satiety and decrease hunger

These reactions can damage sensitive amino acid residues within the peptide chain, reducing potency and potentially creating degradation products that were not in the original formulation

Early tirzepatide studies also show promising reductions in liver fat

Mori, H., Okada, Y., Arao, T

Harlyn L

"PROTECT-Cog builds directly on what we learned from US POINTER and takes the next critical step in prevention science," said Dr Maria Carrillo, chief science officer and medical affairs lead at the Alzheimer's Association, and principal investigator of the new study